{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:21:35Z","timestamp":1759191695704,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de R\u00e9adaptation et de M\u00e9decine Physique"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.annrmp.2004.10.007","type":"journal-article","created":{"date-parts":[[2005,3,4]],"date-time":"2005-03-04T10:04:06Z","timestamp":1109930646000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Membres sup\u00e9rieurs fonctionnels hypertoniques et toxine botulique. Quels r\u00e9sultats fonctionnels\u00a0?"],"prefix":"10.1016","volume":"48","author":[{"given":"A.-L.","family":"Ferrapie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vieillart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Saint-Cast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Menei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annrmp.2004.10.007_bib1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0003-9993(94)90918-0","article-title":"Clinical effectiveness of botulinum toxin in distal upper extremity spasticity among patients with traumatic brain injury","volume":"75","author":"Agana","year":"1994","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.annrmp.2004.10.007_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-2000-15289","article-title":"Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia","volume":"31","author":"Autti-Ram\u00f6","year":"2000","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.annrmp.2004.10.007_bib3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport\u00ae) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.annrmp.2004.10.007_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur J Neurol"},{"year":"2003","series-title":"Guide des outils de mesure et d\u2019\u00e9valuation en m\u00e9decine physique et de r\u00e9adaptation","author":"B\u00e9thoux","key":"10.1016\/j.annrmp.2004.10.007_bib5"},{"key":"10.1016\/j.annrmp.2004.10.007_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.61.1.30","article-title":"Use of botulinum toxin in stroke patients with severe upper limb spasticity","volume":"61","author":"Bhakta","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.annrmp.2004.10.007_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","article-title":"Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial","volume":"69","author":"Bhakta","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annrmp.2004.10.007_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified ashworth scale of muscle spasticity","author":"Bohannon","year":"1987","journal-title":"Phys Ther"},{"key":"10.1016\/j.annrmp.2004.10.007_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annrmp.2004.10.007_bib10","series-title":"La spasticit\u00e9","first-page":"137","article-title":"Injections de toxine botulique A et spasticit\u00e9 du membre sup\u00e9rieur\u00a0: l\u2019exp\u00e9rience st\u00e9phanoise","author":"Chaleat-Valayer","year":"2001"},{"key":"10.1016\/j.annrmp.2004.10.007_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/pgmj.65.762.208","article-title":"Effect of treatment with botulinum toxin on spasticity","volume":"65","author":"Das","year":"1989","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.annrmp.2004.10.007_bib12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1297-3203(01)00049-X","article-title":"The DASH questionnaire. French translation of a trans-cultural adaptation","volume":"20","author":"Dubert","year":"2001","journal-title":"Chir Main"},{"key":"10.1016\/j.annrmp.2004.10.007_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0168-6054(03)00108-9","article-title":"Toxine botulique et traumatisme cr\u00e2nien","volume":"46","author":"Duprey","year":"2003","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.annrmp.2004.10.007_bib14","first-page":"55","article-title":"Le bilan 400 points","volume":"19","author":"Gable","year":"1989","journal-title":"Revue de r\u00e9adaptation fonctionnelle, professionnelle et sociale"},{"key":"10.1016\/j.annrmp.2004.10.007_bib15","first-page":"72","article-title":"Accords inter-juges d\u2019une mesure fonctionnelle analytique du membre sup\u00e9rieur. Inter-rater agreements of an analytic functional measure of the upper limb","volume":"41","author":"Gable","year":"1993","journal-title":"Rev Epid\u00e9m et Sant\u00e9 Publ"},{"key":"10.1016\/j.annrmp.2004.10.007_bib16","first-page":"47","article-title":"Bilan 400 points","volume":"18","author":"Gable","year":"1996","journal-title":"Journal d\u2019Ergoth\u00e9rapie"},{"key":"10.1016\/j.annrmp.2004.10.007_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0168-6054(97)83377-6","article-title":"\u00c9valuation fonctionnelle de la main. Bilan 400 points et tests chiffr\u00e9s","volume":"40","author":"Gable","year":"1997","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.annrmp.2004.10.007_bib18","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1097\/00001756-199709290-00008","article-title":"Botulinum toxin upper limb spasticity: study of reciprocal inhibition between forearm muscles","volume":"8","author":"Girlanda","year":"1997","journal-title":"Neuroreport"},{"issue":"Suppl 8","key":"10.1016\/j.annrmp.2004.10.007_bib19","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1002\/mds.20065","article-title":"Physiological effects of botulinum toxin in spasticity","volume":"19","author":"Gracies","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.annrmp.2004.10.007_bib20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.45.4.712","article-title":"Botulinum toxin A for spasticity, muscle spasms, and rigidity","volume":"45","author":"Grazko","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.annrmp.2004.10.007_bib21","series-title":"La spasticit\u00e9","first-page":"119","article-title":"Management of upper and lower limb spasticity in neurorehabilitation","author":"Hesse","year":"2001"},{"key":"10.1016\/j.annrmp.2004.10.007_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/apmr.2003.50001","article-title":"Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection","volume":"84","author":"Hurvitz","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.annrmp.2004.10.007_bib23","series-title":"Les mouvements anormaux","first-page":"121","article-title":"Mouvements anormaux chez le c\u00e9r\u00e9brol\u00e9s\u00e9 vasculaire","author":"Leblond","year":"2004"},{"key":"10.1016\/j.annrmp.2004.10.007_bib24","first-page":"248","article-title":"Unidimensionnalit\u00e9 d\u2019une mesure fonctionnelle pour des malades ayant une l\u00e9sion du membre sup\u00e9rieur","volume":"44","author":"Luquet","year":"1996","journal-title":"Rev Epid\u00e9miol et Sant\u00e9 Publ"},{"key":"10.1016\/j.annrmp.2004.10.007_bib25","first-page":"212","article-title":"Traitement de la spasticit\u00e9 par la toxine botulique","volume":"148","author":"Memin","year":"1992","journal-title":"Rev Neurol"},{"key":"10.1016\/j.annrmp.2004.10.007_bib26","first-page":"168","article-title":"La mesure d\u2019ind\u00e9pendance fonctionnelle\u00a0: historique, pr\u00e9sentation, perspectives","volume":"11","author":"Minaire","year":"1991","journal-title":"J Readapt Med"},{"key":"10.1016\/j.annrmp.2004.10.007_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0168-6054(03)00102-8","article-title":"Apport de l\u2019EMG dans l\u2019utilisation de la toxine botulique","volume":"46","author":"Monnier","year":"2003","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.annrmp.2004.10.007_bib28","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1002\/(SICI)1097-4598(1997)6+<176::AID-MUS12>3.0.CO;2-4","article-title":"Injection techniques for botulinum toxin using electromyography and electrical stimulation","volume":"20","author":"O\u2019Brien","year":"1997","journal-title":"Muscle Nerve Suppl."},{"key":"10.1016\/j.annrmp.2004.10.007_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00002060-199807000-00020","article-title":"Botulinum toxin treatment of lumbrical spasticity: a brief report","volume":"77","author":"Palmer","year":"1998","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.annrmp.2004.10.007_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp.64.3.419","article-title":"Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury","volume":"64","author":"Pavesi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annrmp.2004.10.007_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0003-9993(96)90015-5","article-title":"Botulinum toxin A in the treatment of spasticity: functional implications and patient selection","volume":"77","author":"Pierson","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.annrmp.2004.10.007_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archneur.1996.00550070055012","article-title":"Approach to the treatment of limb disorders with botulinum toxin A: Experience with 187 patients","volume":"53","author":"Pullman","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.annrmp.2004.10.007_bib33","first-page":"47","article-title":"Disability changes after treatment of upper limb spasticity with botulinum toxin","volume":"10","author":"Reiter","year":"1996","journal-title":"J Neuro Rehab"},{"key":"10.1016\/j.annrmp.2004.10.007_bib34","unstructured":"R\u00e9my-N\u00e9ris O, Denys P, Azouvi P, Jouffroy A, Faivre S, Laurans A, et al. Spasticit\u00e9. Encycl M\u00e9d Chir (Elsevier Paris), Kin\u00e9sith\u00e9rapie- M\u00e9decine Physique-R\u00e9adaptation, 26-011-A-10, 1997, 8p."},{"key":"10.1016\/j.annrmp.2004.10.007_bib35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/026921559701100404","article-title":"The effect of botulinum toxin on hand function after incomplete spinal cord injury at the level of C5\/6 : a case report","volume":"11","author":"Richardson","year":"1997","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.annrmp.2004.10.007_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/PL00007851","article-title":"Efficacy of botulinum toxin A in upper limb function of hemiplegic patients","volume":"249","author":"Rousseaux","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.annrmp.2004.10.007_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0168-6054(03)00112-0","article-title":"H\u00e9mipl\u00e9gie vasculaire\u00a0: int\u00e9r\u00eat de l\u2019injection de toxine botulique au membre sup\u00e9rieur","volume":"46","author":"Rousseaux","year":"2003","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.annrmp.2004.10.007_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026921559701100102","article-title":"Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients","volume":"11","author":"Sampaio","year":"1997","journal-title":"Clin Rehab"},{"key":"10.1016\/j.annrmp.2004.10.007_bib39","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: a randomised, double blind, placebo-controlled trial","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.annrmp.2004.10.007_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/026921500666642221","article-title":"A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury","volume":"14","author":"Smith","year":"2000","journal-title":"Clin Rehab"},{"key":"10.1016\/j.annrmp.2004.10.007_bib41","first-page":"413","article-title":"Botulinum treatment for post-stroke spasticity : low dose regime","volume":"81","author":"Viriyavejakul","year":"1998","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.annrmp.2004.10.007_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/09638289809166055","article-title":"A study of the effectiveness of botulinum toxin type A (Dysport\u00ae) in the management of muscle spasticity","volume":"20","author":"Watanabe","year":"1998","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.annrmp.2004.10.007_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000073058","article-title":"Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients?","volume":"50","author":"Woldag","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.annrmp.2004.10.007_bib44","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.47.4.939","article-title":"Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial","volume":"47","author":"Yablon","year":"1996","journal-title":"Neurology"}],"container-title":["Annales de R\u00e9adaptation et de M\u00e9decine Physique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168605405000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168605405000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:57:10Z","timestamp":1759172230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168605405000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0168605405000371"],"URL":"https:\/\/doi.org\/10.1016\/j.annrmp.2004.10.007","relation":{},"ISSN":["0168-6054"],"issn-type":[{"type":"print","value":"0168-6054"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membres sup\u00e9rieurs fonctionnels hypertoniques et toxine botulique. Quels r\u00e9sultats fonctionnels\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales de R\u00e9adaptation et de M\u00e9decine Physique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annrmp.2004.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}